Prosecution Insights
Last updated: August 06, 2026

Lowry Blixseth Apc

8 pending office actions • 8 clients • 8 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Quality Metrics (n=419 apps, methodology: how we score firms)

91.4%
Allowance Rate
n=419
+0.59σ
Allowance Rate (norm)
n=419
3.2
OAs to Allowance
n=265
-0.37σ
OAs to Allow (norm)
n=265
1076 days
Time to Allowance
n=265
+3.4pp
Interview Lift
n=419
22.4%
RCE Rate
n=419
4.2%
Appeal Rate
n=419

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=18 (min 20)
82.6%
§102 Overcome
n=98
78.3%
§103 Overcome
n=161
81.8%
§112 Overcome
n=121

Specialization & Scale

A61F, A47G, A61K
Top CPC Subclasses
14%
Top-3 CPC Share
n=419
3
Practitioners
n=419
139.7
Apps / Practitioner
n=419

Portfolio Summary

8
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (38%)
5
Medium (62%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (12%)
§103 only5 (62%)
Multi-statute (no §101)2 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
25% of docket
2
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KATCHEVES, BASIL S 1 72.2% +17.2%
GINES, GEORGE SAMUEL 1 70.2% +40.2%
LEE, SHIN 1 66.7% +100.0%
HOEKSTRA, JEFFREY GERBEN 1 55.7% +39.6%
COHEN, MICHAEL P 1 58.7% +27.2%
TRUONG, QUANGLONG N 1 78.8% +23.5%
TUROCY, DAVID P 1 47.0% +35.5%
EBBINGHAUS, BRIANA NOEL 1 62.3% +61.4%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19014120 TRI-LAYER BED COVER GINES, GEORGE SAMUEL 23d
18869773 SYSTEM AND METHOD FOR EVALUATING BEDSORE RISK HOEKSTRA, JEFFREY GERBEN
17267166 NANOPARTICLES FOR TRANSFECTION EBBINGHAUS, BRIANA NOEL

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19351176 SLAB SUPPORT KATCHEVES, BASIL S 23d overdue
18438087 USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION COHEN, MICHAEL P 8d overdue
19014120 TRI-LAYER BED COVER GINES, GEORGE SAMUEL 23d
18983324 PROCESSES AND SYSTEMS FOR HEADPHONE TUNING LEE, SHIN
18869773 SYSTEM AND METHOD FOR EVALUATING BEDSORE RISK HOEKSTRA, JEFFREY GERBEN
18281135 USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY TRUONG, QUANGLONG N
17713791 PROCESSES FOR PRODUCING ORTHOPEDIC IMPLANTS HAVING A SUBSURFACE LEVEL CERAMIC LAYER APPLIED VIA BOMBARDMENT TUROCY, DAVID P
17267166 NANOPARTICLES FOR TRANSFECTION EBBINGHAUS, BRIANA NOEL

Client Portfolio (8 clients)

Top Art Units

Art UnitApps
36331
36731
16121
16241
17181
16321

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19351176 SLAB SUPPORT Safeboard LLC KATCHEVES, BASIL S 3633 §103 Non-Final OA 23d overdue Pending Oct 06, 2025
19014120 TRI-LAYER BED COVER Keeco, LLC GINES, GEORGE SAMUEL 3673 §102§103 Non-Final OA 23d Pending Jan 08, 2025
18983324 PROCESSES AND SYSTEMS FOR HEADPHONE TUNING Yellow Matter Entertainment, LLC LEE, SHIN §103 Non-Final OA Pending Dec 16, 2024
18869773 SYSTEM AND METHOD FOR EVALUATING BEDSORE RISK Neo Able Co., Ltd. HOEKSTRA, JEFFREY GERBEN §101§102§112 Non-Final OA Pending Nov 26, 2024
18438087 USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION Invion, Inc. COHEN, MICHAEL P 1612 §103 Final Rejection 8d overdue Pending Feb 09, 2024
18281135 USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY Chronic Airway Therapeutics Limited TRUONG, QUANGLONG N 1624 §103 Non-Final OA Pending Sep 08, 2023
17713791 PROCESSES FOR PRODUCING ORTHOPEDIC IMPLANTS HAVING A SUBSURFACE LEVEL CERAMIC LAYER APPLIED VIA BOMBARDMENT Joint Development, LLC TUROCY, DAVID P 1718 §103 Final Rejection Pending Apr 05, 2022
17267166 NANOPARTICLES FOR TRANSFECTION Loxegen Holdings Pty Ltd. EBBINGHAUS, BRIANA NOEL 1632 §103§112Other Non-Final OA Pending Feb 09, 2021

Managing Lowry Blixseth Apc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month